Cloning and variation of ground state intestinal stem cells

Nature

Volumn 522, Issue 7555, 2015, Pages 173-178

  Wang, Xia ^a   Yamamoto, Yusuke ^a   Wilson, Lane H ^a,b   Zhang, Ting ^c   Howitt, Brooke E ^d   Farrow, Melissa A ^e   Kern, Florian ^c   Ning, Gang ^a   Hong, Yue ^a   Khor, Chiea Chuen ^c,f   Chevalier, Benoit ^a   Bertrand, Denis ^c   Wu, Lingyan ^c   Nagarajan, Niranjan ^c   Sylvester, Francisco A ^g   Hyams, Jeffrey S ^h   Devers, Thomas ^b   Bronson, Roderick ⁱ   Lacy, D Borden ^e   Ho, Khek Yu ^j   Crum, Christopher P ^d   McKeon, Frank ^a,c,j,k   Xian, Wa ^a,b,d,j,k   more..

^a JACKSON LABORATORY   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c GENOME INSTITUTE OF SINGAPORE   (Singapore)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h Farmington   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^k Multiclonal Therapeutics Inc   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; BETA CATENIN; CYTOKERATIN 20; EPIDERMAL GROWTH FACTOR; MUCIN 2; NOTCH RECEPTOR; SOMATOMEDIN; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR GATA 6; TRANSFORMING GROWTH FACTOR BETA; VILLIN; WNT PROTEIN; CLOSTRIDIUM DIFFICILE LETHAL TOXIN B;

CLONE; CYTOLOGY; PATHOGENICITY; TOXIN;

ARTICLE; CELL CLONING; CELL COUNT; CELL DIFFERENTIATION; CELL SUSPENSION; CLONAL VARIATION; CLONOGENESIS; CLOSTRIDIUM DIFFICILE INFECTION; EMBRYONIC STEM CELL; EPIGENETICS; GENE EXPRESSION; GENE FREQUENCY; GENETIC ANALYSIS; GENOMIC INSTABILITY; HOX GENE; HUMAN; HUMAN CLONING; INTESTINAL STEM CELL; MOLECULAR WEIGHT; NONHUMAN; PEDIGREE; PEPTOCLOSTRIDIUM DIFFICILE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH EPITHELIUM; CELL CLONE; CELL CULTURE; CELL LINEAGE; COLON; CYTOLOGY; CYTOPLASM; DRUG EFFECTS; EPITHELIUM; FETUS; GENETIC EPIGENESIS; GENETICS; GROWTH, DEVELOPMENT AND AGING; INTESTINE; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; PSEUDOMEMBRANOUS COLITIS; SMALL INTESTINE; STEM CELL;

CLOSTRIDIUM DIFFICILE;

BACTERIAL TOXINS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; CLONE CELLS; CLOSTRIDIUM DIFFICILE; COLON; ENTEROCOLITIS, PSEUDOMEMBRANOUS; EPIGENESIS, GENETIC; EPITHELIUM; FETUS; GENOMIC INSTABILITY; HUMANS; INTESTINE, SMALL; INTESTINES; ORGANOIDS; STEM CELLS;

EID: 84931268960     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature14484     Document Type: Article

References (58)

1. Tabar, V., Studer, L. Pluripotent stem cells in regenerative medicine: challenges and recent progress. Nature Rev. Genet. 15, 82-92 (2014).
2. Okano, H., Yamanaka, S. iPS cell technologies: significance and applications to CNS regeneration and disease. Mol. Brain 7, 22 (2014).
3. Mü ller, A. M., Dzierzak, E. A. ES cells have only a limited lymphopoietic potential after adoptive transfer into mouse recipients. Development 118, 1343-1351 (1993).
4. Helgason, C. D., Sauvageau, G., Lawrence, H. J., Largman, C., Humphries, R. K. Overexpression of HOXB4 enhances the hematopoietic potential of embryonic stem cells differentiated in vitro. Blood 87, 2740-2749 (1996).
5. Bonde, S., Dowden, A. M., Chan, K. M., Tabayoyong, W. B. & Zavazava, N. HOXB4but not BMP4 confers self-renewal properties to ES-derived hematopoietic progenitor cells. Transplantation 86, 1803-1809 (2008).
6. Iuchi, S., Dabelsteen, S., Easley, K., Rheinwald, J. G., Green, H. Immortalized keratinocyte lines derived fromhuman embryonic stemcells. Proc. Natl Acad. Sci. USA 103, 1792-1797 (2006).
7. Amabile, G. et al. In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. Blood 121, 1255-1264 (2013).
8. Suzuki, N. et al. Generation of engraftable hematopoietic stemcells from induced pluripotent stem cells by way of teratoma formation. Mol. Ther. 21, 1424-1431 (2013).
9. Rheinwatd, J. G., Green, H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6, 331-343 (1975).
10. Rama, P. et al. Limbal stem-cell therapy and long-term corneal regeneration. N. Engl. J. Med. 363, 147-155 (2010).
11. Senoo, M., Pinto, F., Crum, C. P., McKeon, F. p63 is essential for the proliferative potential of stem cells of stratified epithelia. Cell 129, 523-536 (2007).
12. Kumar, P. A. et al. Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell 147, 525-538 (2011).
13. Matsuura, R. et al. Crucial transcription factors in endoderm and embryonic gut development are expressed in gut-like structures from mouse ES cells. Stem Cells 24, 624-630 (2006).
14. Sato, T. et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262-265 (2009).
15. Ootani, A. et al. Sustained in vitro intestinal epithelial culture within a Wntdependent stem cell niche. Nature Med. 15, 701-706 (2009).
16. Sato, T. et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469, 415-418 (2011).
17. Fordham, R. P. et al. Transplantation of expanded fetal intestinal progenitors contributes to colon regeneration after injury. Cell Stem Cell 13, 734-744 (2013).
18. Middendorp, S. et al. Adult stem cells in the small intestine are intrinsically programmed with their location-specific function. Stem Cells 32, 1083-1091 (2014).
19. Yin, X. et al. Niche-independent high-purity cultures of Lgr51 intestinal stemcells and their progeny. Nature Methods 11, 106-112 (2014).
20. Kim, K. A. et al. Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science 309, 1256-1259 (2005).
21. Dreesen, O., Brivanlou, A. H. Signaling pathways in cancer and embryonic stem cells. Stem Cell Rev. 3, 7-17 (2007).
22. Zhu, L. et al. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 457, 603-607 (2009).
23. Barker, N. et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003-1007 (2007).
24. Powell, A. E. et al. The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell 149, 146-158 (2012).
25. Botrugno, O. A. et al. Synergy between LRH-1 and beta-catenin induces G1 cyclinmediated cell proliferation. Mol. Cell 15, 499-509 (2004).
26. Lessard, J., Sauvageau, G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423, 255-260 (2003).
27. Sangiorgi, E., Capecchi, M. R. Bmi1 is expressed in vivo in intestinal stem cells. Nature Genet. 40, 915-920 (2008).
28. Tian, H. et al. A reserve stemcell population insmall intestine renders Lgr5-positive cells dispensable. Nature 478, 255-259 (2011).
29. Metcalfe, C., Kljavin, N. M., Ybarra, R., de Sauvage, F. J. Lgr51 stem cells are indispensable for radiation-induced intestinal regeneration. Cell Stem Cell 14, 149-159 (2014).
30. Battle, M. A. et al. GATA4 is essential for jejunal function in mice. Gastroenterology 135, 1676-1686 (2008).
31. Walker, E. M., Thompson, C. A. & Battle, M. A. GATA4 andGATA6 regulate intestinal epithelial cytodifferentiation duringdevelopment. Dev. Biol. 392, 283-294(2014).
32. Dusing, M. R., Maier, E. A., Aronow, B. J., Wiginton, D. A. Onecut-2 knockout mice fail to thrive during early postnatal period and have altered patterns of gene expression in small intestine. Physiol. Genomics 42, 115-125 (2010).
33. International Stem Cell Initiative. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nature Biotechnol. 29, 1132-1144 (2011).
34. Avery, S. et al. BCL-XL mediates the strong selective advantage of a 20q11. 21 amplification commonly found in human embryonic stemcell cultures. Stem Cell Rep. 1, 379-386 (2013).
35. Shultz, L. D. et al. Human cancer growth and therapy in immunodeficient mouse models. Cold Spring Harb Protoc. http://dx. doi. org/10. 1101/pdb. top073585 (2014).
36. Voth, D. E., Ballard, J. D. Clostridium difficile toxins: mechanismof action and role in disease. Clin. Microbiol. Rev. 18, 247-263 (2005).
37. Carter, G. P., Rood, J. I., Lyras, D. The role of toxin A and toxin B in the virulence of Clostridium difficile. Trends Microbiol. 20, 21-29 (2012).
38. Lyras, D. et al. Toxin B is essential for virulence of Clostridium difficile. Nature 458, 1176-1179 (2009).
39. Farrow, M. A. et al. Clostridiumdifficile toxin B-induced necrosis is mediated by the host epithelial cell NADPH oxidase complex. Proc. Natl Acad. Sci. USA 110, 18674-18679 (2013).
40. Huelsenbeck, J. et al. Upregulation of the immediate early gene product RhoB by exoenzyme C3 from Clostridium limosum and toxin B from Clostridium difficile. Biochemistry 46, 4923-4931 (2007).
41. Aktories, K., Schmidt, G. & Just, I. RhoGTPases as targets ofbacterial protein toxins. Biol. Chem. 381, 421-426 (2000).
42. MacFie, T. S. et al. DUOX2 and DUOXA2 form the predominant enzyme system capable of producing the reactive oxygen species H2O2 in active ulcerative colitis and are modulated by 5-aminosalicylic acid. Inflamm. Bowel Dis. 20, 514-524 (2014).
43. Cheng, H., Leblond, C. P. Origin, differentiation and renewal of the four main epithelial cell types in themouse small intestine. V. Unitarian theory of the origin of the four epithelial cell types. Am. J. Anat. 141, 537-561 (1974).
44. Yui, S. et al. Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr51 stem cell. Nature Med. 18, 618-623 (2012).
45. Wang, F. et al. Isolation and characterization of intestinal stem cells based on surface marker combinations and colony-formation assay. Gastroenterology 145, 383-395 (2013).
46. Watson, C. L. et al. Anin vivomodel ofhumansmall intestine using pluripotent stem cells. Nature Med. 20, 1310-1314 (2014).
47. Sheaffer, K. L., Kaestner, K. H. Transcriptional networks in liver and intestinal development. Cold Spring Harb. Perspect. Biol. 4, a008284 (2012).
48. Nicholson, J. K. et al. Host-gut microbiota metabolic interactions. Science 336, 1262-1267 (2012).
49. Brandl, K., Beutler, B. Creating diseases to understand what prevents them: genetic analysis of inflammation in the gastrointestinal tract. Curr. Opin. Immunol. 24, 678-685 (2012).
50. Lees, C. W., Barrett, J. C., Parkes, M., Satsangi, J. New IBD genetics: common pathways with other diseases. Gut 60, 1739-1753 (2011).
51. Schmidt, D., Hübsch, U., Wurzer, H., Heppt, W., Aufderheide, M. Development of an in vitro humannasal epithelial (HNE) cellmodel. Toxicol. Lett. 88, 75-79 (1996).
52. Chumbler, N. M. et al. Clostridium difficile toxin B causes epithelial cell necrosis through an autoprocessing-independent mechanism. PLoS Pathog. 8, e1003072 (2012).
53. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005).
54. Wang, K. et al. PennCNV: an integrated hidden Markov model designed for highresolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. 17, 1665-1674 (2007).
55. Li, H., Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler Transform. Bioinformatics 25, 1754-1760 (2009).
56. McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297-1303 (2010).
57. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
58. Wang, K., Li, M., Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).